HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

✍ Scribed by Michael A. Singer; Carl C. Awh; SriniVas Sadda; William R. Freeman; Andrew N. Antoszyk; Pamela Wong; Lisa Tuomi

• Book ID: 116806511
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 423 KB
• Volume: 119
• Category: Article
• ISSN: 0161-6420
• DOI: 10.1016/j.ophtha.2011.12.016